Cardinal Health
- Market cap
- 53.76B
- P/E (TTM)i
- 32.11
- P/Bi
- -18.65
- EPSi
- 7.23
- Div yieldi
- 0.88%
- 52W posi
- 76%
Anonymous reader poll. Unscientific, not investment advice.
Cardinal Health last traded at 232.16, down 0.55% on the session. The company carries a market value of roughly 53.76B, the #429 most valuable US-listed company we track. Valuation-wise, the P/E sits at 30.77, broadly in line with the five-year average of 30.62. The stock also carries a trailing dividend yield of 0.88%. The 14 analysts covering the stock are, on balance, at Buy, targeting an average of 270.00 (+16%). The shares sit 76% of the way up their 52-week range of 150.45 to 257.70.
✦ StockVane Quant Insights how this is computed
- Twelve-month momentum in the top 17% of the universe, above its 200-day average.
- Signal has read BUY for 2 months.
- Its last 3 Buy calls have averaged close to flat (+1%) three months out - no strong edge on this name specifically.
- Recent price momentum is +23.3% on average (3-month/1-year).
- Main-fund capital flow has been a net outflow over the last 45 sessions.
- Short interest has risen to 2.9% of float.
- Analyst tilt is Buy.
- Price is above its 20-day average and above its 60-day average.
- The 20-day average is below the 60-day average, a short-term downtrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Factor grades
Ranked against 977 U.S. stocks StockVane covers.
Valuation B-
How expensive the stock is versus earnings, sales and its own 5-year history.
| P/E (TTM) | 32.2x | Better than 25% |
| Forward P/E | 22.2x | Better than 36% |
| Price / Sales | 0.2x | Better than 99% |
| P/E vs own 5-yr range | 56th pctl | Better than 53% |
Growth A-
How fast revenue, profit and free cash flow are compounding.
| Revenue CAGR (3Y) | 7.4% | Better than 54% |
| Net income CAGR (3Y) | 73.2% | Better than 95% |
| Free cash flow CAGR (3Y) | 24.2% | Better than 69% |
Profitability F
How much profit the business keeps from each dollar of sales and capital.
| Gross margin | 3.8% | Better than 1% |
| Operating margin | 1.2% | Better than 11% |
| Net margin | 0.7% | Better than 15% |
| Return on equity | -172.5% | Better than 1% |
| Return on invested capital | -13.0% | Better than 6% |
Momentum B+
Recent price strength, skipping the latest month to avoid short-term noise.
| 3-month return | -2.5% | Better than 48% |
| 6-month return | 10.0% | Better than 57% |
| 12-month return (ex latest month) | 60.4% | Better than 85% |
| Distance below 52-week high | 9.5% | Better than 78% |
Financial Health B
Balance-sheet strength: leverage, liquidity and interest coverage.
| Current ratio | 0.9x | Better than 18% |
| Debt to assets | 15.5% | Better than 70% |
| Interest coverage | 7.2x | Better than 54% |
| Free cash flow / net income | 264.0% | Better than 89% |
Analyst View B-
What the Street thinks: share of Buy ratings and upside to the average target.
| Analysts rating Buy | 85.7% | Better than 66% |
| Upside to average target | 15.8% | Better than 29% |
Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector, so capital-light software tends to grade lower there than utilities. Recomputed every 6 hours from our market data. Not investment advice, and not tailored to your financial situation, goals, or risk tolerance.
Price chart
Performance
Key statistics
Price & volume
- Prev close
- 233.44
- Open
- 233.61
- Day range
- 230.61 - 235.97
- Avg price
- 232.47
- Volume
- 1.10M
- Turnover
- 255.00M
- Turnover ratei
- 0.48%
- Volume ratioi
- 0.63
- Amplitudei
- 2.30%
- 52-week rangei
- 150.45 - 257.70
Valuation
- P/Ei
- 32.11
- P/E (TTM)i
- 32.11
- P/Bi
- -18.65
- EPSi
- 7.23
- Book value / shi
- -12.45
- Net profit
- 1.67B
- Net assets
- -2.88B
Share structure
- Market cap
- 53.76B
- Float capi
- 53.63B
- Shares out
- 231.56M
- Float sharesi
- 231.02M
Dividend & listing
- Div yield (TTM)i
- 0.88%
- Dividend (TTM)
- 2.05
- Listing date
- 1970-01-01
9.9% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
-33.37M net over the window
Short interest
- Shares short
- 6.67M
- % of floati
- 2.87%
- Days to coveri
- 4.58
- As of
- 2026-09-15
Frequently asked questions
What is the current stock price of Cardinal Health (CAH)?
Cardinal Health last traded at 232.16. The quote on this page refreshes every few seconds while US markets are open.
What is Cardinal Health's market cap?
About 53.76B.
What is the P/E ratio of Cardinal Health?
The trailing twelve-month P/E is 32.11, above its own 5-year average of 30.62 — in the middle of its historical range (56.34% percentile). See the Valuation tab for the full history.
Does Cardinal Health pay a dividend?
Yes. The trailing dividend yield is 0.88%. The 2025 payout was up 34.4% from 2024. See the Dividends tab for the full payment history.
Is Cardinal Health a buy according to analysts?
The consensus of 14 analysts is a Buy rating, with an average 12-month price target of 270.00, which implies 16.3% upside from the current price. This is not investment advice.
What is Cardinal Health's StockVane Quant Rating?
The StockVane Momentum strategy currently rates Cardinal Health a B (Buy). Twelve-month momentum in the top 17% of the universe, above its 200-day average. Not investment advice.
Quote time 2026-10-08 09:02:09 · For reference only, not investment advice and not tailored to your situation.